Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Ethyl isonicotinate is an organic compound belonging to the pyridine family, characterized by its clear colorless to light brown liquid appearance. It serves as a versatile building block in the synthesis of various pharmaceutical and biologically active compounds, making it a valuable component in the development of new drugs and therapies.

1570-45-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1570-45-2 Structure
  • Basic information

    1. Product Name: Ethyl isonicotinate
    2. Synonyms: 4-Carbethoxypyridine;4-Carboethoxypyridine;gamma-Pyridinecarboxylic acid ethyl ester;pyridine-4-carboxylicacidethylester;ETHYL PYRIDINE-4-CARBOXYLATE;ETHYL ISONICOTINATE;ETHYL 4-PYRIDINECARBONATE;ETHYL 4-PYRIDINECARBOXYLATE
    3. CAS NO:1570-45-2
    4. Molecular Formula: C8H9NO2
    5. Molecular Weight: 151.16
    6. EINECS: 216-379-2
    7. Product Categories: CARBOXYLICESTER;C7 and C8;Heterocyclic Building Blocks;Pyridines;Building Blocks;C8;Chemical Synthesis;Heterocyclic Building Blocks
    8. Mol File: 1570-45-2.mol
  • Chemical Properties

    1. Melting Point: 23°C
    2. Boiling Point: 92 °C8 mm Hg(lit.)
    3. Flash Point: 190 °F
    4. Appearance: clear colorless to light brown liquid
    5. Density: 1.009 g/mL at 25 °C(lit.)
    6. Vapor Pressure: 0.119mmHg at 25°C
    7. Refractive Index: n20/D 1.501(lit.)
    8. Storage Temp.: Store below +30°C.
    9. Solubility: H2O: soluble
    10. PKA: pK1:3.45(+1) (25°C)
    11. Water Solubility: immiscible
    12. Merck: 14,5187
    13. BRN: 122942
    14. CAS DataBase Reference: Ethyl isonicotinate(CAS DataBase Reference)
    15. NIST Chemistry Reference: Ethyl isonicotinate(1570-45-2)
    16. EPA Substance Registry System: Ethyl isonicotinate(1570-45-2)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36
    4. RIDADR: NA 1993 / PGIII
    5. WGK Germany: 3
    6. RTECS: NS1450000
    7. TSCA: Yes
    8. HazardClass: N/A
    9. PackingGroup: N/A
    10. Hazardous Substances Data: 1570-45-2(Hazardous Substances Data)

1570-45-2 Usage

Uses

Used in Pharmaceutical Synthesis:
Ethyl isonicotinate is used as an organic building block for the synthesis of various pharmaceutical compounds. Its unique structure and properties allow it to be a key component in the development of new drugs and therapies, contributing to the advancement of medical treatments.
Used in Biologically Active Compounds:
Ethyl isonicotinate is also used as a building block in the synthesis of biologically active compounds. Its incorporation into these compounds can enhance their effectiveness and potential applications in various fields, including medicine and biotechnology.
Used in Pest Control:
Ethyl isonicotinate is used as a trapping agent for thrips in the agricultural industry. Its ability to trap these pests makes it a valuable tool in integrated pest management strategies, helping to protect crops and reduce the need for chemical pesticides.

Safety Profile

Poison by intravenous route. When heated to decomposition it emits toxic fumes of NOx.

Check Digit Verification of cas no

The CAS Registry Mumber 1570-45-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,7 and 0 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1570-45:
(6*1)+(5*5)+(4*7)+(3*0)+(2*4)+(1*5)=72
72 % 10 = 2
So 1570-45-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H9NO2/c1-2-11-8(10)7-3-5-9-6-4-7/h3-6H,2H2,1H3

1570-45-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L03010)  Ethyl isonicotinate, 98%   

  • 1570-45-2

  • 100g

  • 572.0CNY

  • Detail
  • Alfa Aesar

  • (L03010)  Ethyl isonicotinate, 98%   

  • 1570-45-2

  • 500g

  • 2290.0CNY

  • Detail
  • Aldrich

  • (104736)  Ethylisonicotinate  98%

  • 1570-45-2

  • 104736-100G

  • 683.28CNY

  • Detail
  • Aldrich

  • (104736)  Ethylisonicotinate  98%

  • 1570-45-2

  • 104736-500G

  • 2,809.17CNY

  • Detail
  • Aldrich

  • (104736)  Ethylisonicotinate  98%

  • 1570-45-2

  • 104736-100G

  • 683.28CNY

  • Detail
  • Aldrich

  • (104736)  Ethylisonicotinate  98%

  • 1570-45-2

  • 104736-500G

  • 2,809.17CNY

  • Detail
  • Aldrich

  • (104736)  Ethylisonicotinate  98%

  • 1570-45-2

  • 104736-100G

  • 683.28CNY

  • Detail
  • Aldrich

  • (104736)  Ethylisonicotinate  98%

  • 1570-45-2

  • 104736-500G

  • 2,809.17CNY

  • Detail
  • Aldrich

  • (104736)  Ethylisonicotinate  98%

  • 1570-45-2

  • 104736-100G

  • 683.28CNY

  • Detail
  • Aldrich

  • (104736)  Ethylisonicotinate  98%

  • 1570-45-2

  • 104736-500G

  • 2,809.17CNY

  • Detail

1570-45-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl isonicotinate

1.2 Other means of identification

Product number -
Other names 4-Pyridinecarboxylic acid, ethyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1570-45-2 SDS

1570-45-2Relevant articles and documents

Synthesis, characterization, antioxidant activities, and DNA-binding studies of (E)-N′-[1-(pyridin-2-yl)ethylidene]isonicotinohydrazide and its Pr(III) and Nd(III) complexes

Hao, Zhong-Yan,Liu, Qi-Wan,Xu, Jun,Jia, Lei,Li, Shao-Bai

, p. 1306 - 1312 (2010)

A new ligand, (E)-N′-[1-(pyridin-2-yl)ethylidene]isonicotinohydrazide (HL), was prepared by condensation of 2-acetylpyridine and isonicotinohydrazide in ethanol. Its two lanthanide(III) complexes, [NdIII(L) 2(NO3)(CH3OH)2]?CH 3CH2OH (1), and [PrIII(L)2(NO 3)(CH3OH)2]?CH3CH 2OH (2), have been synthesized and characterized on the basis of element analyses, molar conductivities and IR spectra. The structure of complex 2 has been confirmed by X-ray diffraction. In addition, the DNA-binding properties of the two complexes have been investigated by electronic absorption spectroscopy, fluorescence spectroscopy, circular dichroic (CD) spectroscopy and viscosity measurements. The experimental results suggest that the two complexes bind to DNA via a groove binding mode, and the binding affinity of complex 2 is higher than that of complex 1. Furthermore, the antioxidant activities (superoxide and hydroxyl radical) of the ligand and its metal complexes were determined by spectrophotometry methods in vitro. These complexes were found to possess potent antioxidant activity and be superior to standard antioxidant like mannitol.

Adamantyl derivative as a potent inhibitor of plasmodium FK506 binding protein 35

Harikishore, Amaravadhi,Leow, Min Li,Niang, Makhtar,Rajan, Sreekanth,Pasunooti, Kalyan Kumar,Preiser, Peter Rainer,Liu, Xuewei,Yoon, Ho Sup

, p. 1097 - 1101 (2013)

FKBP35, FK506 binding protein family member, in Plasmodium species displays a canonical peptidyl-prolyl isomerase (PPIase) activity and is intricately involved in the protein folding process. Inhibition of PfFKBP35 by FK506 or its analogues were shown to interfere with the in vitro growth of Plasmodium falciparum. In this study, we have synthesized adamantyl derivatives, Supradamal (SRA/4a) and its analogues SRA1/4b and SRA2/4c, which demonstrate submicromolar inhibition of Plasmodium falciparum FK506 binding domain 35 (FKBD35) PPIase activity. SRA and its analogues not only inhibit the in vitro growth of Plasmodium falciparum 3D7 strain but also show stage specific activity by inhibiting the trophozoite stage of the parasite. SRA/4a also inhibits the Plasmodium vivax FKBD35 PPIase activity and our crystal structure of PvFKBD35 in complex with the SRA provides structural insights in achieving selective inhibition against Plasmodium FKBPs.

Transition metal complexes of N′-(2-(hydroxyimino)propanoyl)isonicotinohydrazide: Synthesis, characterization, DNA interaction and anticancer evaluation

Hegde, Divya,Naik, Ganesh N.,Vadavi, Ramesh S.,Shyam Kumar,Barretto, Delicia A.,Gudasi, Kalagouda B.

, p. 301 - 315 (2017)

A new tetradentate chelating ligand, N′-(2-(hydroxyimino)propanoyl)isonicotinohydrazide and its selective transition metal complexes have been synthesized and evaluated for anticancer behavior. The ligand structure was determined by single-crystal X-ray crystallography. All complexes were investigated by elemental, thermogravimetric analysis, IR, NMR, ESI Mass and electronic spectroscopic studies. The ligand exhibited monoclinic lattice structure with Cc space group, having 4 ligand molecules in each unit cell. The geometrical isomerism (E and Z) was observed in ligand due to the restricted rotation along the >C[dbnd]N– functional group. The interaction of ligand and complexes with calf-thymus DNA (CT-DNA) has been extensively studied using absorption, emission, viscosity and thermal denaturation studies with E. coli DNA. The DNA cleavage properties were screened using plasmid pBR322 DNA by gel electrophoresis method. Complexes have been evaluated for their in vitro antiproliferative activity against human cancer cells of different origin such as MCF-7, Mia-Pa-Ca-2 and DU-145 by using SRB (sulforhodamine B) assay, in which iron complex have shown better antiproliferative activity compared to remaining complexes.

Development of a Novel Chemoenzymatic Process for (S)-1-(Pyridin-4-yl)-1,3-propanediol

Chen, Shao-Xin,Peng, Peng,Tang, Jia-Wei,Wang, Hong-Yi,Yan, Hai-Jun,Zhang, Fu-Li

, p. 2890 - 2897 (2020)

We first developed a novel and efficient chemoenzymatic process to prepare (S)-1-(pyridin-4-yl)-1,3-propanediol, a vital HepDirect prodrug intermediate, from inexpensive and commercially available isonicotinic acid. Through this process, we provide a creative way to obtain the key chiral intermediate, β-hydroxyester, with ketoreductase (KRED) EA. After optimization of the process, we performed the reaction on a 100 g scale with a substrate concentration of up to 150 g/L, a yield of 93%, and an ee value of up to 99.9%. Additionally, we used a simple and effective NaBH4/MgCl2 reduction system to obtain (S)-1-(pyridin-4-yl)-1,3-propanediol with >99.9% ee and an 80% yield. This novel chemoenzymatic process has the potential to be a cost-effective and environmentally friendly process suitable for industrial use.

Pleuromutilin derivative with 1, 3, 4-oxadiazole side chain and preparation and application thereof

-

Paragraph 0055-0056; 0070; 0090; 0092; 0095; 0102, (2021/07/24)

The invention belongs to the field of medicinal chemistry, and particularly relates to a pleuromutilin derivative with a 1, 3, 4-oxadiazole side chain and preparation and application thereof The pleuromutilin derivative with the 1, 3, 4-oxadiazole side chain is a compound shown in a formula 2 or a pharmaceutically acceptable salt thereof, and a solvent compound, an enantiomer, a diastereoisomer and a tautomer of the compound shown in the formula 2 or the pharmaceutically acceptable salt thereof or a mixture of the solvent compound, the enantiomer, the diastereoisomer and the tautomer in any proportion, including a racemic mixture. The pleuromutilin derivative has good antibacterial activity, is especially suitable for being used as a novel antibacterial agent for systemic system infection of animals or human beings, and has good water solubility.

Metal-Free Deoxygenation of Amine N-Oxides: Synthetic and Mechanistic Studies

Lecroq, William,Schleinitz, Jules,Billoue, Mallaury,Perfetto, Anna,Gaumont, Annie-Claude,Lalevée, Jacques,Ciofini, Ilaria,Grimaud, Laurence,Lakhdar, Sami

, p. 1237 - 1242 (2021/06/01)

We report herein an unprecedented combination of light and P(III)/P(V) redox cycling for the efficient deoxygenation of aromatic amine N-oxides. Moreover, we discovered that a large variety of aliphatic amine N-oxides can easily be deoxygenated by using only phenylsilane. These practically simple approaches proceed well under metal-free conditions, tolerate many functionalities and are highly chemoselective. Combined experimental and computational studies enabled a deep understanding of factors controlling the reactivity of both aromatic and aliphatic amine N-oxides.

Fluorovinylsulfones and -Sulfonates as Potent Covalent Reversible Inhibitors of the Trypanosomal Cysteine Protease Rhodesain: Structure-Activity Relationship, Inhibition Mechanism, Metabolism, and in Vivo Studies

Jung, Sascha,Fuchs, Natalie,Johe, Patrick,Wagner, Annika,Diehl, Erika,Yuliani, Tri,Zimmer, Collin,Barthels, Fabian,Zimmermann, Robert A.,Klein, Philipp,Waigel, Waldemar,Meyr, Jessica,Opatz, Till,Tenzer, Stefan,Distler, Ute,R?der, Hans-Joachim,Kersten, Christian,Engels, Bernd,Hellmich, Ute A.,Klein, Jochen,Schirmeister, Tanja

, p. 12322 - 12358 (2021/09/02)

Rhodesain is a major cysteine protease of Trypanosoma brucei rhodesiense, a pathogen causing Human African Trypanosomiasis, and a validated drug target. Recently, we reported the development of α-halovinylsulfones as a new class of covalent reversible cysteine protease inhibitors. Here, α-fluorovinylsulfones/-sulfonates were optimized for rhodesain based on molecular modeling approaches. 2d, the most potent and selective inhibitor in the series, shows a single-digit nanomolar affinity and high selectivity toward mammalian cathepsins B and L. Enzymatic dilution assays and MS experiments indicate that 2d is a slow-tight binder (Ki = 3 nM). Furthermore, the nonfluorinated 2d-(H) shows favorable metabolism and biodistribution by accumulation in mice brain tissue after intraperitoneal and oral administration. The highest antitrypanosomal activity was observed for inhibitors with an N-terminal 2,3-dihydrobenzo[b][1,4]dioxine group and a 4-Me-Phe residue in P2 (2e/4e) with nanomolar EC50 values (0.14/0.80 μM). The different mechanisms of reversible and irreversible inhibitors were explained using QM/MM calculations and MD simulations.

Development of Novel (+)-Nootkatone Thioethers Containing 1,3,4-Oxadiazole/Thiadiazole Moieties as Insecticide Candidates against Three Species of Insect Pests

Cheng, Wanqing,Fan, Jiangping,Guo, Yong,Han, Meiyue,Ma, Nannan,Yan, Xiaoting,Yang, Ruige

, p. 15544 - 15553 (2022/01/03)

To improve the insecticidal activity of (+)-nootkatone, a series of 42 (+)-nootkatone thioethers containing 1,3,4-oxadiazole/thiadiazole moieties were prepared to evaluate their insecticidal activities against Mythimna separata Walker, Myzus persicae Sulzer, and Plutella xylostella Linnaeus. Insecticidal evaluation revealed that most of the title derivatives exhibited more potent insecticidal activities than the precursor (+)-nootkatone after the introduction of 1,3,4-oxadiazole/thiadiazole on (+)-nootkatone. Among all of the (+)-nootkatone derivatives, compound 8c (1 mg/mL) exhibited the best growth inhibitory (GI) activity against M. separata with a final corrected mortality rate (CMR) of 71.4%, which was 1.54- and 1.43-fold that of (+)-nootkatone and toosendanin, respectively; 8c also displayed the most potent aphicidal activity against M. persicae with an LD50 value of 0.030 μg/larvae, which was closer to that of the commercial insecticidal etoxazole (0.026 μg/larvae); and 8s showed the best larvicidal activity against P. xylostella with an LC50 value of 0.27 mg/mL, which was 3.37-fold that of toosendanin and slightly higher than that of etoxazole (0.28 mg/mL). Furthermore, the control efficacy of 8s against P. xylostella in the pot experiments under greenhouse conditions was better than that of etoxazole. Structure-activity relationships (SARs) revealed that in most cases, the introduction of 1,3,4-oxadiazole/thiadiazole containing halophenyl groups at the C-13 position of (+)-nootkatone could obtain more active derivatives against M. separata, M. persicae, and P. xylostella than those containing other groups. In addition, toxicity assays indicated that these (+)-nootkatone derivatives had good selectivity to insects over nontarget organisms (normal mammalian NRK-52E cells and C. idella and N. denticulata fries) with relatively low toxicity. Therefore, the above results indicate that these (+)-nootkatone derivatives could be further explored as new lead compounds for the development of potential eco-friendly pesticides.

Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker

Liu, Jie,Zhang, Guang-Yu,Zhang, Zhe,Li, Bo,Chai, Fei,Wang, Qi,Zhou, Zi-Dan,Xu, Ling-Ling,Wang, Shou-Kai,Jin, Zhen,Tang, You-Zhi

, (2021/05/17)

A class of pleuromutilin derivatives containing 1, 3, 4-oxadiazole were designed and synthesized as potential antibacterial agents against Methicillin-resistant staphylococcus aureus (MRSA). The ultrasound-assisted reaction was proposed as a green chemistry method to synthesize 1, 3, 4-oxadiazole derivatives (intermediates 85–110). Among these pleuromutilin derivatives, compound 133 was found to be the strongest antibacterial derivative against MRSA (MIC = 0.125 μg/mL). Furthermore, the result of the time-kill curves displayed that compound 133 could inhibit the growth of MRSA in vitro quickly (- 4.36 log10 CFU/mL reduction). Then, compound 133 (- 1.82 log10 CFU/mL) displayed superior in vivo antibacterial efficacy than tiamulin (- 0.82 log10 CFU/mL) in reducing MRSA load in mice thigh model. Besides, compound 133 exhibited low cytotoxicity to RAW 264.7 cells. Molecular docking studies revealed that compound 133 was successfully localized in the binding pocket of 50S ribosomal subunit (ΔGb = -10.50 kcal/mol). The results indicated that these pleuromutilin derivatives containing 1, 3, 4-oxadiazole might be further developed into novel antibiotics against MRSA.

A facile and versatile electro-reductive system for hydrodefunctionalization under ambient conditions

Huang, Binbin,Guo, Lin,Xia, Wujiong

supporting information, p. 2095 - 2103 (2021/03/26)

A general electrochemical system for reductive hydrodefunctionalization is described, employing the inexpensive and easily available triethylamine (Et3N) as a sacrificial reductant. This protocol is characterized by facile operation, sustainable conditions, and exceptionally wide substrate scope covering the cleavage of C-halogen, N-S, N-C, O-S, O-C, C-C and C-N bonds. Notably, the selectivity and capability of reduction can be conveniently switched by simple incorporation or removal of an alcohol as a co-solvent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1570-45-2